Clinical Trials
3 trialsNCT00244816 2025-10-23
Taxoprexin® Treatment for Advanced Eye Melanoma
American Regent, Inc.
Phase 2 Completed
NCT00249262 2025-09-26
Taxoprexin Treatment for Advanced Skin Melanoma
American Regent, Inc.
Phase 2 Completed
NCT01032343 2013-08-22
An Immunonutritional Approach to the Prevention of Skin Cancer
University of Manchester
Phase NA Completed